Lumosa Therapeutics Co., Ltd. (TPEX:6535)
132.00
+4.00 (3.13%)
May 15, 2026, 1:30 PM CST
-17.76% (1Y)
| Market Cap | 21.44B -19.7% |
| Revenue (ttm) | 31.42M -8.5% |
| Net Income | -356.04M |
| EPS | -2.13 |
| Shares Out | 167.49M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 184,202 |
| Average Volume | 244,907 |
| Open | 128.50 |
| Previous Close | 128.00 |
| Day's Range | 127.00 - 135.00 |
| 52-Week Range | 121.00 - 329.50 |
| Beta | 0.22 |
| RSI | 45.26 |
| Earnings Date | May 18, 2026 |